Canadian application, no grantCanada
Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation
CA 2334946 A1 · Owner: Compound Therapeutics, Inc. · Inventors: Lipovsek, Dasa; Hammond, Philip W.
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Described herein are methods for removing the 3'-untranslated regions from cDNA or mRNA molecules, as well as methods for the use of such products for RNA-protein fusion formation.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 16, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 16, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 16, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 16, 1999
GrantedNo grant recorded
Term endedAugust 16, 2019
Patent numberCA 2334946 A1
Classification (IPC)C12P19/34 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.